Norwegian Health AS, as part of the Global Pharma Group AS, is pleased to announce that all five of its new products have officially received market authorization for sale in Germany. The approvals were granted based on expert evaluations conducted by a government-appointed research and testing laboratory. The issued certificates confirm that the products comply with current legal requirements and are approved for distribution.
The approved products include:
- ArtroShield® – for joint support
- L-Serin Memory® – to enhance cognitive performance
- BioDigestin™ – for digestive health
- Schwarzer Knoblauch – for heart and immune support
- YoungerYou NAD+ – for cellular regeneration and energy
“These approvals mark a significant milestone for our company. They enable us to officially enter the German market – one of the most important markets for dietary supplements in Europe,” said Andreas Meyer, Marketing Lead for Norwegian Health AS.
The products will be available in Germany starting summer 2025 through online channels as well as selected pharmacies and specialty retailers. Further product launches across European markets are already in planning.
About Norwegian Health AS
Norwegian Health AS, based in Sykkylven, Norway, with focus on international markets specializes in premium dietary supplements developed with innovative ingredients and grounded in scientific research.
